ZLDAF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Zelira Therapeutics (ZLDAF) Ownership - Who owns Zelira Therapeutics?

Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

101 St Georgeâ€™s Terrace

Phone

+61 865580886

Employees

Web

https://www.zeliratx.com

Details

Group

Domestic Stock Funds

Fundamentals

ZLDAF

Capitalization

3.33M

P/E Ratio

N/A

Risk (Beta)

2.26

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.00%

Revenue

40.9K

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-0.42

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

0.94

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-3.17M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-172.57

Shares Held By Institutions

N/A

Shares Outstanding - Current

11.9M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

-21.723

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology